| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22 |
| filingDate |
2010-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c5f152c657e49618356bb6dcb530c0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1623d66e14496dd76a2d90c7a6f11bf |
| publicationDate |
2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110006703-A |
| titleOfInvention |
Solid Form of Aliskiren Compound |
| abstract |
The present invention relates to solid forms of the pharmaceutically acceptable compounds of aliskiren and methods for their preparation. The present invention provides a pharmaceutical formulation comprising the amorphous form or the crystalline form of the pharmaceutically acceptable compound of aliskiren and a method for preparing the same; And a method of inhibiting renin to treat high blood pressure. |
| priorityDate |
2009-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |